Supplementary Table 6 from A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27025868
I
Ian T. Shelton
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
55
Papers
163
Citations
5
h-index
4
i10-index
Ian T. Shelton is an academic researcher from University of Colorado Anschutz Medical Campus. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Retinoids in leukemia and cellular processes & Acute Lymphoblastic Leukemia research. The author has an h-index of 5, co-authored 47 publications.
ORCID: 0000-0001-5974-2736Papers by this author
worksSupplementary Table 7 from A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27025865
Supplementary Table 7 from A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27025865.v1
Supplementary Figures S1-S7 from A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27025877
Supplementary Figures S1-S7 from A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27025877.v1
Supplementary Table 1 from A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27025874
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat